Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to SRCIN1 (None established)
- Target
- None established
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01
Overview
Novel transcript, antisense to SRCIN1 is a non-coding RNA (NAT/lncRNA) transcribed from the strand opposite to the SRCIN1 gene. Natural antisense transcripts like this one are recognized for their potential roles in regulating the expression of their sense partner genes, possibly through mechanisms such as RNA interference, RNA stability modulation, or chromatin remodeling. While similar NATs have been shown to play roles in neurological development and disease in other contexts, direct evidence for the biological function or therapeutic relevance of this specific transcript is lacking[1]. To date, it is not annotated as a standard drug target and has no known disease mutations, biomarkers, or direct pharmacological interactions.
- Other names
- antisense to SRCIN1
02
Mechanism of action
Not applicable; not a validated target for drug intervention
03
Biological functions
Likely post-transcriptional regulation of SRCIN1 expressionPossible roles in cis or trans gene expression regulationSpecific function remains unvalidated and largely unknown
04
Disease associations
Other (possible involvement in neurological or developmental disease, inferred from general NAT functions, not specifically established for this transcript)
Beyond the preview
Go deeper on Novel transcript, antisense to SRCIN1 (None established).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to SRCIN1 (None established).